Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Eastman Chemical Company (EMN) SEC filings page provides access to the company’s regulatory disclosures as a public issuer on the New York Stock Exchange. As a global specialty materials company in the plastics material and resin manufacturing industry, Eastman files periodic and current reports that describe its financial condition, results of operations, governance matters, and material events.
Among the most closely watched documents are annual reports on Form 10-K and quarterly reports on Form 10-Q, which include segment information, discussions of end-market demand in areas such as transportation, building and construction, and consumables, and commentary on topics like cash generation, cost structure, and specialty materials performance. Current reports on Form 8-K provide timely updates on specific events, including quarterly earnings releases, Board and executive changes, and other matters the company deems material.
Investors can also review proxy statements for information on Board composition, committee assignments, and director compensation, as well as filings related to executive compensation and governance. For those monitoring insider activity, Forms 3, 4, and 5 disclose transactions by directors and officers in Eastman’s common stock.
On this page, AI-powered tools summarize lengthy filings, highlight key sections, and help explain complex topics such as non-GAAP measures like adjusted EBIT and adjusted earnings per diluted share that Eastman discusses in its earnings materials. Real-time updates from the SEC’s EDGAR system ensure that new EMN filings, including 10-K, 10-Q, 8-K, and Form 4 submissions, are available quickly, allowing users to review the underlying disclosures and the AI-generated insights side by side.
Eastman Chemical CEO and board chair Mark J. Costa reported a tax-related share disposition. On the payout of performance shares for the 2023-2025 performance period, 25,260 shares of common stock were withheld to cover tax obligations at a price of $80.26 per share. After this withholding, Costa directly owns 497,929 shares of Eastman Chemical common stock, and indirectly holds 3,227 shares through an ESOP arrangement.
Eastman Chemical executive Stephen Glenn Crawford, EVP and Chief Technology and Sustainability Officer, had 4,720 shares of common stock withheld on February 18, 2026 at $80.26 per share to cover tax obligations from a 2023–2025 performance share payout. After this tax-withholding disposition, he holds 67,714 common shares directly, plus additional indirect holdings through 401(k) and ESOP accounts for himself and his spouse.
Eastman Chemical Company is offering $600,000,000 aggregate principal amount of 4.500% notes due February 20, 2031.
The notes pay interest at 4.500% semi-annually on February 20 and August 20, beginning August 20, 2026, and are unsecured obligations that will rank equally with Eastman’s other unsecured and unsubordinated debt. Eastman expects to receive approximately $593.7 million in net proceeds and intends to use them for general corporate purposes, including working capital, capital expenditures and potential repayment of indebtedness.
The indenture permits optional redemption prior to maturity at prescribed redemption prices and requires Eastman to offer to repurchase the notes at 101% of principal if a Change of Control Triggering Event occurs. The notes will not be listed on an exchange and have no established trading market.
Eastman Chemical Company plans an offering of new unsecured, unsubordinated senior notes under its existing shelf registration. The notes will pay fixed semi-annual interest and mature on a specified future date, with no sinking fund and minimum denominations of $2,000.
The notes may be redeemed early at Eastman’s option, with a make-whole premium before a specified par call date and at par thereafter. If a defined change of control triggering event occurs, holders can require Eastman to repurchase the notes at 101% of principal plus accrued interest.
The notes will rank equally with Eastman’s other unsecured, unsubordinated debt; as of December 31, 2025, this included approximately $4.8 billion of debt. They will be structurally subordinated to obligations of subsidiaries. Eastman expects to use net proceeds for general corporate purposes, including working capital, capital spending, debt repayment, and strategic initiatives.
Eastman Chemical executive Brad A. Lich reported an equity award of company stock. On February 11, 2026, the EVP & CCO acquired 18,861 shares of Eastman Chemical common stock at $0 per share as a grant based on performance for the three-year 2023–2025 period.
After this award, Lich beneficially owned 102,348 common shares directly, plus 2,594 shares indirectly through a 401(k) plan and 1,251 shares indirectly through an ESOP, reflecting his combined direct and plan-based holdings in Eastman Chemical.
McLain William Thomas Jr. reported acquisition or exercise transactions in a Form 4 filing for EMN. The filing lists transactions totaling 15,883 shares. Following the reported transactions, holdings were 69,784 shares.
Eastman Chemical executive Stephen G. Crawford received an equity award of company stock. On February 11, 2026, he acquired 12,133 shares of Eastman Chemical common stock at a price of $0 per share, reported as a grant or award tied to performance.
This award, based on the determination of performance shares earned for the three-year 2023–2025 period, increased his direct holdings to 72,434 common shares. He also reports indirect ownership through benefit and retirement plans: 459 shares by a 401(k) plan, 296 shares by his spouse in an ESOP, 1,134 shares by an ESOP, and 64 shares by his spouse in a 401(k) plan.
Stewart Michelle Renee reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Controller and Chief Accounting Officer Michelle Renee Stewart received an award of 3,309 shares of common stock on February 11, 2026 at a price of $0 per share. The award reflects the determination of performance shares earned for the three-year 2023–2025 performance period. Following this grant, she directly owns 8,272 Eastman Chemical common shares.
Costa Mark J reported acquisition or exercise transactions in a Form 4 filing for EMN. The filing lists transactions totaling 64,192 shares. Following the reported transactions, holdings were 523,189 shares.
Eastman Chemical executive Julie A. McAlindon reported an equity award of company stock. On February 11, 2026, she acquired 7,280 shares of Eastman Chemical common stock at a price of $0 per share, reported as a grant, award, or other acquisition.
The footnote explains this reflects the determination of performance shares earned for the three-year 2023–2025 performance period, meaning the award was tied to multi‑year performance goals. After this grant, McAlindon directly beneficially owned 20,011 common shares, and indirectly beneficially owned an additional 887 shares through an ESOP.